![Ralph Smalling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ralph Smalling
Director/Board Member at
SYMBIO PHARMACEUTICALS LIMITED
Net worth: 198 776 $ as of 2026-07-30
Profile
Ralph Smalling is currently an Outside Director at SymBio Pharmaceuticals Ltd. and Vice President & Head-Regulatory Affairs at Genelux Corp.
since 2023.
The education history includes graduate studies at The California State University and undergraduate studies at Occidental College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENELUX CORP. 0.15% | 2026-06-02 | 67,611 ( 0.15% ) | 198 776 $ | 2026-07-30 |
Ralph Smalling active positions
| Companies | Position | Start |
|---|---|---|
| GENELUX CORPORATION | General Counsel | 2023-07-19 |
| SYMBIO PHARMACEUTICALS LIMITED | Director/Board Member | - |
Training of Ralph Smalling
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
31
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Genelux Corp.
 Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SymBio Pharmaceuticals Ltd.
 SymBio Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutics for cancer and other related diseases | Health Technology |
- Stock Market
- Insiders
- Ralph Smalling
